Skip to search formSkip to main contentSkip to account menu

idursulfase

Known as: Alpha-L-iduronate sulfate sulfatase, idursulfase [Chemical/Ingredient] 
National Institutes of Health

Related topics

Related topics

8 relations
3 ML idursulfase 2 MG/ML Injection [Elaprase]Alpha-glucosidaseIDS geneIDS protein, human

Narrower (1)

Elaprase

Broader (1)

Iduronate Sulfatase

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2017
Review
2017
Clinical outcomes in idursulfase-treated patients with mucopolysaccharidosis type II: 3-year data from the hunter outcome survey (HOS)
BackgroundMucopolysaccharidosis type II (MPS II; Hunter syndrome) is a rare, X-linked disorder caused by deficient activity of… 
2016
2016
Comparative study of idursulfase beta and idursulfase in vitro and in vivo
Hunter syndrome is an X-linked lysosomal storage disease caused by a deficiency in the enzyme iduronate-2-sulfatase (IDS… 
2014
2014
Comparative study on mannose 6-phosphate residue contents of recombinant lysosomal enzymes.
Highly Cited
2013
Highly Cited
2013
Phase I/II clinical trial of enzyme replacement therapy with idursulfase beta in patients with mucopolysaccharidosis II (Hunter Syndrome)
BackgroundMucopolysaccharidosis II (MPS II, Hunter syndrome) is a rare X-linked lysosomal storage disorder caused by the… 
2013
2013
IgE‐mediated anaphylaxis and allergic reactions to idursulfase in patients with Hunter syndrome
Enzyme replacement therapy (ERT) with recombinant human idursulfase is effective for the treatment of Hunter syndrome… 
Highly Cited
2010
Highly Cited
2010
Japan Elaprase Treatment (JET) study: idursulfase enzyme replacement therapy in adult patients with attenuated Hunter syndrome (Mucopolysaccharidosis II, MPS II).
2010
2010
Hunter syndrome in an 11-year old girl on enzyme replacement therapy with idursulfase: brain magnetic resonance imaging features and evolution
Mucopolysaccharidosis type II (MPS-II, Hunter disease) is a X-linked recessive disorder. Affected females are extremely rare… 
Review
2008
Review
2008
Enzyme replacement therapy with idursulfase in patients with mucopolysaccharidosis type II
Mucopolysaccharidosis type II (MPS II; Hunter syndrome) is a rare X‐linked recessive disease caused by deficiency of the… 
Review
2008
Review
2008
Review of the use of idursulfase in the treatment of mucopolysaccharidosis II
Mucopolysaccharidosis type II (MPS II, Hunter syndrome) is a heterogeneous, progressive X-linked recessively inherited lysosomal… 
Review
2008
Review
2008
Idursulfase for the treatment of mucopolysaccharidosis II.
Human recombinant proteins are being used to treat an increasing number of disorders. Advances in the large scale production of… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)